BG101408A - Аналози на кератиноцитния растежен фактор - Google Patents

Аналози на кератиноцитния растежен фактор

Info

Publication number
BG101408A
BG101408A BG101408A BG10140897A BG101408A BG 101408 A BG101408 A BG 101408A BG 101408 A BG101408 A BG 101408A BG 10140897 A BG10140897 A BG 10140897A BG 101408 A BG101408 A BG 101408A
Authority
BG
Bulgaria
Prior art keywords
growth factor
kgf
keratinotine
analysis
epithelial cell
Prior art date
Application number
BG101408A
Other languages
English (en)
Other versions
BG63167B1 (bg
Inventor
Charles Morris
William Kenney
Bao-Lu Chen
Erik Hsu
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of BG101408A publication Critical patent/BG101408A/bg
Publication of BG63167B1 publication Critical patent/BG63167B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до аналози на силен митоген на растежа на нефибробластни епителни клетки, кератиноцитен растежен фактор (KGF), модифициран допървите 24 N-крайни аминокиселини, където цистеиновите остатъци, съответстващи на позициите на аминокиселини 1 и 15 на KGF [позиции 32 и 46 на аминокиселини от SEQ ID NO:2, (съответно Cys1 и Cys15)],са заличени или заместени с друга аминокиселина. Изобретението се отнася и до молекули на нуклеинови киселини, които кодират такива аналози, и до методи за използването на такива аналози за стимулиране пролиферацията на нефибробластни епителни клетки.
BG101408A 1994-10-13 1997-04-11 Аналози на кератиноцитния растежен фактор BG63167B1 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32347594A 1994-10-13 1994-10-13
US32334094A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
PCT/IB1995/000971 WO1996011949A2 (en) 1994-10-13 1995-10-12 Analogs of keratinocyte growth factor

Publications (2)

Publication Number Publication Date
BG101408A true BG101408A (bg) 1997-12-30
BG63167B1 BG63167B1 (bg) 2001-05-31

Family

ID=27406268

Family Applications (2)

Application Number Title Priority Date Filing Date
BG101392A BG101392A (bg) 1994-10-13 1997-04-07 Метод за лечение на захарен диабет с използване на кератиноцитен растителен фактор
BG101408A BG63167B1 (bg) 1994-10-13 1997-04-11 Аналози на кератиноцитния растежен фактор

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG101392A BG101392A (bg) 1994-10-13 1997-04-07 Метод за лечение на захарен диабет с използване на кератиноцитен растителен фактор

Country Status (23)

Country Link
EP (2) EP0804479B1 (bg)
JP (2) JP4216329B2 (bg)
KR (1) KR100278597B1 (bg)
CN (1) CN1168678A (bg)
AT (2) ATE237633T1 (bg)
AU (1) AU3707795A (bg)
BG (2) BG101392A (bg)
BR (2) BR9509269A (bg)
CA (2) CA2202075C (bg)
CZ (3) CZ297329B6 (bg)
DE (2) DE69530403T2 (bg)
DK (2) DK0804479T3 (bg)
EE (2) EE9700225A (bg)
ES (2) ES2196082T3 (bg)
FI (2) FI971420L (bg)
HU (2) HU226168B1 (bg)
NO (2) NO971566L (bg)
NZ (2) NZ505502A (bg)
PL (2) PL320484A1 (bg)
PT (2) PT785948E (bg)
SI (2) SI0785948T1 (bg)
SK (2) SK43197A3 (bg)
WO (2) WO1996011950A1 (bg)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20022681B (en) 1989-01-31 2002-04-25 Aaronson Us Stuart A Protein KFG, Antibodies, Pharmaceutical Composition, Their Use, recombinant DNA, Cell, Method for Discoveries and Production of Proteins, Method for Stimulation of Epithelial Cells Growth
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
BR9407035A (pt) 1993-06-29 1996-03-12 Chiron Corp Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme
SI0785949T1 (en) * 1994-10-13 2003-08-31 Amgen Inc. Method for purifying keratinocyte growth factors
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
AU5410196A (en) * 1995-04-27 1996-11-18 Cooperatie Suiker Unie U.A. Inulin derivatives
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
DK0935652T3 (da) * 1996-10-15 2004-07-26 Amgen Inc Keratinocyt vækstfaktor-2 produkter
EP1473366A1 (en) * 1996-10-15 2004-11-03 Amgen Inc. Keratinocyte growth factor-2 products
CN1269805A (zh) 1997-07-14 2000-10-11 博尔德生物技术公司 生长激素和相关蛋白的衍生物
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
KR20010033484A (ko) 1997-12-22 2001-04-25 휴먼 게놈 사이언시즈, 인크. 각질세포 성장 인자-2 제제
US6242666B1 (en) * 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
JP2002534119A (ja) * 1999-01-14 2002-10-15 ボルダー バイオテクノロジー， インコーポレイテッド 自由システイン残基を有するタンパク質の生産方法
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
US20040063634A1 (en) * 2001-01-19 2004-04-01 Carr Francis J. Modified kertinocyte growth factor (kgf) with reduced immunogenicity
AU2007214362B2 (en) * 2001-08-21 2009-11-26 Novartis Vaccines And Diagnostics, Inc. KGF polypeptide compositions
JP2005500390A (ja) 2001-08-21 2005-01-06 カイロン コーポレイション Ｋｇｆポリペプチド組成物
CA2589889C (en) 2004-12-15 2013-07-30 Amgen Inc. Therapeutic formulations of keratinocyte growth factor
CN102242124B (zh) * 2010-05-10 2013-05-22 齐鲁制药有限公司 改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
WO1990000877A1 (en) * 1988-07-27 1990-02-08 Marjan International Pty Ltd Carpet stretcher
GEP20022681B (en) * 1989-01-31 2002-04-25 Aaronson Us Stuart A Protein KFG, Antibodies, Pharmaceutical Composition, Their Use, recombinant DNA, Cell, Method for Discoveries and Production of Proteins, Method for Stimulation of Epithelial Cells Growth
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
JP3578761B2 (ja) * 1993-03-26 2004-10-20 アムジエン・インコーポレーテツド 表皮ケラチン細胞成長因子の治療目的での使用
US5348563A (en) * 1993-06-29 1994-09-20 Honeywell Inc. Air purifying apparatus
BR9407035A (pt) * 1993-06-29 1996-03-12 Chiron Corp Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme
GB9315501D0 (en) * 1993-07-27 1993-09-08 Ici Plc Surfactant compositions
CA2168647A1 (en) * 1993-08-02 1995-02-09 Barbara A. Sosnowski Monogenous preparations of cytotoxic conjugates

Also Published As

Publication number Publication date
FI971536L (fi) 1997-06-09
NZ335109A (en) 2000-08-25
SI0804479T1 (sl) 2006-12-31
JP4216329B2 (ja) 2009-01-28
CZ297328B6 (cs) 2006-11-15
CZ297329B6 (cs) 2006-11-15
SK284534B6 (sk) 2005-06-02
NO971566D0 (no) 1997-04-04
FI971536A0 (fi) 1997-04-11
BR9509329A (pt) 1997-10-14
ATE237633T1 (de) 2003-05-15
EP0785948A1 (en) 1997-07-30
ATE342278T1 (de) 2006-11-15
NO971568D0 (no) 1997-04-04
EP0785948B1 (en) 2003-04-16
DK0785948T3 (da) 2003-08-04
CA2202075A1 (en) 1996-04-25
BG101392A (bg) 1997-10-31
PL319784A1 (en) 1997-08-18
HU226168B1 (en) 2008-05-28
FI971420A0 (fi) 1997-04-04
WO1996011950A1 (en) 1996-04-25
CN1168678A (zh) 1997-12-24
PT785948E (pt) 2003-09-30
SK43197A3 (en) 1999-03-12
BR9509269A (pt) 1997-12-23
CA2202075C (en) 2003-12-09
NO318761B1 (no) 2005-05-02
DE69530403T2 (de) 2003-10-30
KR100278597B1 (ko) 2001-01-15
AU681546B2 (en) 1997-08-28
SI0785948T1 (en) 2003-08-31
JPH10507193A (ja) 1998-07-14
NO971566L (no) 1997-04-14
DE69530403D1 (de) 2003-05-22
ES2273338T3 (es) 2007-05-01
CA2201940C (en) 2009-05-12
AU3708395A (en) 1996-05-06
AU3707795A (en) 1996-05-06
FI971420A7 (fi) 1997-04-04
PT804479E (pt) 2007-02-28
CA2201940A1 (en) 1996-04-25
HUT78058A (hu) 1999-07-28
FI120040B (fi) 2009-06-15
JPH10507080A (ja) 1998-07-14
PL182888B1 (pl) 2002-03-29
NZ505502A (en) 2005-01-28
EP0804479A1 (en) 1997-11-05
NO971568L (no) 1997-06-12
EE9700081A (et) 1997-10-15
CZ98197A3 (cs) 1998-11-11
HUT78050A (hu) 1999-07-28
FI971420L (fi) 1997-04-04
ES2196082T3 (es) 2003-12-16
EE9700225A (et) 1998-02-16
DE69535264T2 (de) 2007-02-01
BG63167B1 (bg) 2001-05-31
WO1996011949A2 (en) 1996-04-25
EP0804479B1 (en) 2006-10-11
CZ105097A3 (cs) 1998-10-14
DE69535264D1 (de) 2006-11-23
JP4426646B2 (ja) 2010-03-03
DK0804479T3 (da) 2007-01-29
WO1996011949A3 (en) 1996-12-12
PL320484A1 (en) 1997-09-29
EE03975B1 (et) 2003-02-17
SK45597A3 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
WO1996011949A3 (en) Analogs of keratinocyte growth factor
KR880010130A (ko) 폴리 펩티드, dna 및 그의 용도
DE69738586D1 (de) Hohe expressionsrate von proteinen
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
ATE272109T1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
DE69132814D1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
DE69333346D1 (de) Neuartiges p- selectin ligandenprotein
PT785950E (pt) Analogos do factor de crescimento de queratinocitos
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
BR0309401A (pt) polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo
PT81418A (en) Process to obtain antibodies for human non-small lung cell carcinomas
EP0546074A4 (en) Genetic material encoding igfbp-5
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
ATE160288T1 (de) Antikörper, ihre herstellung und verwendung
ATE263239T1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
ATE356831T1 (de) Neuer galaninrezeptor
EP0750040A3 (en) Macrophage stimulating protein variant and method for producing the same
ATE141947T1 (de) Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen